A Study of LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced Solid Tumors

by | Jun 25, 2026 | Clinical Trials | 0 comments

​ Conditions: Advanced Solid Tumor

Interventions: Drug: LM-168; Drug: Tislelizumab; Drug: Docetaxel injection

Sponsors: LaNova Medicines Limited

Not yet recruiting Conditions: Advanced Solid Tumor
Interventions: Drug: LM-168; Drug: Tislelizumab; Drug: Docetaxel injection
Sponsors: LaNova Medicines Limited
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *